Regis Corp Files Supplemental Proxy Materials

TL;DR

Regis Corp sent more info for the shareholder vote, vote now!

AI Summary

Regis Corporation filed a DEFA14A on November 5, 2024, providing supplemental information to shareholders regarding their upcoming vote. The filing reminds shareholders to vote and references a previous communication on September 26, 2024. Regis Corporation is a personal services company incorporated in Minnesota.

Why It Matters

This filing provides additional information to shareholders before a vote, ensuring they have the latest details to make informed decisions regarding company matters.

Risk Assessment

Risk Level: low — This filing is a routine proxy statement providing supplemental information and does not indicate any immediate financial or operational risks.

Key Players & Entities

• REGIS CORP (company) — Registrant
• 0000716643 (company) — Central Index Key
• November 5, 2024 (date) — Filing Date
• September 26, 2024 (date) — Previous Communication Date

FAQ

Filing Documents

• ny20038158x1_defa14a.htm (DEFA14A) — 84KB
• ny20038158x1_img1.jpg (GRAPHIC) — 427KB
• ny20038158x1_img2.jpg (GRAPHIC) — 367KB
• 0001140361-24-045153.txt ( ) — 1177KB

SECURITY OWNERSHIP OF CERTAIN

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT The following table sets forth, as of September 1, 2024, the ownership of our common stock by each shareholder who is known by us to own beneficially more than 5% of our outstanding shares, by each director and director nominee, by each named executive officer identified in the Summary Compensation Table, and by all current executive officers, directors and director nominees as a group. Except as indicated below, the parties listed in the table have the sole voting and investment power with respect to the shares indicated. Unless otherwise indicated, the address for each person or entity named below is c/o Regis Corporation, 3701 Wayzata Boulevard, Suite 600, Minneapolis, Minnesota 55416. Our Company had 2,279,948 shares of common stock issued and outstanding as of September 1, 2024. Name of Beneficial Owner or Identity of Group Number of Shares Beneficially Owned 1,2 (#) Percent of Class (%) More than 5% Shareholders First Manhattan Co. LLC 3 221,250 9.7 Named Executive Officers Matthew Doctor 21,991 * Kersten D. Zupfer 10,294 * John C. Davi 6,704 * Directors and Nominees (in addition to Mr. Doctor, who is listed above): Lockie Andrews 6,641 * Nancy Benacci 2,182 * David J. Grissen 16,003 * Mark S. Light 9,526 * Michael Mansbach 6,687 * Michael J. Merriman 10,540 * M. Ann Rhoades 8,953 * All current executive officers, directors, and director nominees as a group (14 persons) 4 124,102 5.3 * less than 1% 1 Includes the following shares not currently outstanding but deemed beneficially owned because of the right to acquire them pursuant to restricted stock units that vest within 60 days or have vested but have not yet been distributed: 2,141 shares for Ms. Andrews, 7,753 shares for Mr. Grissen, 5,026 shares for Mr. Light, 2,187 shares for Mr. Mansbach, 5,540 shares for Mr. Merriman, and 4,453 shares for Ms. Rhoades. 2 Includes the following shares

View Full Filing

View this DEFA14A filing on SEC EDGAR